Secretaria Municipal de Saúde, Prefeitura Municipal, Belo HorizonteMG.
Rev Soc Bras Med Trop. 2013 Sep-Oct;46(5):589-93. doi: 10.1590/0037-8682-0145-2013.
Rapid diagnostic tests (RDTs) may improve the early detection of visceral leishmaniasis (VL), but their real-world performance requires additional study. Therefore, we evaluated the performance of an rK39-based RDT (Kalazar Detect™) for the detection of VL in an endemic, large urban area.
Data were collected from a registry of rK39 RDT performed at 11 emergency care units in Belo Horizonte, Brazil, and from a national database of reportable communicable diseases of the Sistema de Informação de Agravos de Notificação (SINAN).
The rapid rK39 test was performed in 476 patients, with 114 (23.9%) positive results. The analysis of rK39 RDT performance was based on 381 (80%) cases reported to the SINAN database, of which 145 (38.1%) were confirmed cases. Estimates for sensitivity and specificity were 72.4% (95% CI: 64.6-79%) and 99.6% (95%CI: 97.6-99.9%), respectively. Positive and negative predictive values were estimated at 99.1% (95%CI: 94.9-99.8%) and 85.5% (95%CI: 80.8-89.1%), respectively. In addition, close agreement between the rK39 RDT and indirect immunofluorescence was observed.
In summary, the rK39 RDT showed a high specificity but only moderate sensitivity. In endemic areas for VL, treatment may be considered in cases with clinical manifestations and a positive rK39 RDT, but those with a negative test should be subjected to further investigation.
快速诊断检测(RDT)可提高内脏利什曼病(VL)的早期检测,但其实用性能仍需进一步研究。因此,我们评估了一种基于 rK39 的 RDT(Kalazar Detect™)在流行的大型城市地区检测 VL 的性能。
数据来自巴西贝洛奥里藏特的 11 个急诊护理单位的 rK39 RDT 登记册和国家报告传染病 Sistema de Informação de Agravos de Notificação (SINAN) 数据库。
共对 476 例患者进行了快速 rK39 检测,其中 114 例(23.9%)检测结果阳性。rK39 RDT 性能分析基于向 SINAN 数据库报告的 381 例(80%)病例,其中 145 例(38.1%)为确诊病例。敏感性和特异性估计值分别为 72.4%(95%CI:64.6-79%)和 99.6%(95%CI:97.6-99.9%)。阳性和阴性预测值估计值分别为 99.1%(95%CI:94.9-99.8%)和 85.5%(95%CI:80.8-89.1%)。此外,rK39 RDT 与间接免疫荧光之间存在密切一致性。
总之,rK39 RDT 显示出高特异性但仅具有中等敏感性。在 VL 流行地区,对于有临床表现且 rK39 RDT 阳性的患者,可考虑进行治疗,但对于 rK39 检测结果阴性的患者,应进一步进行调查。